相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A randomized clinical trial to evaluate the efficacy and safety of rivaroxaban in patients with bioprosthetic mitral valve and atrial fibrillation or flutter: Rationale and design of the RIVER trial
Helio P. Guimaraes et al.
AMERICAN HEART JOURNAL (2021)
The INVICTUS rheumatic heart disease research program: Rationale, design and baseline characteristics of a randomized trial of rivaroxaban compared to vitamin K antagonists in rheumatic valvular disease and atrial fibrillation
Ganesan Karthikeyan et al.
AMERICAN HEART JOURNAL (2020)
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society
Craig T. January et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Management of atrial fibrillation in patients with rheumatic mitral stenosis
Bernard Iung et al.
HEART (2018)
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
J. W. Eikelboom et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Effects of Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: A Systematic Review and Meta-Analysis
Kuo-Li Pan et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Atrial fibrillation in Sub-Saharan Africa: epidemiology, unmet needs, and treatment options
Bruce Sheldon Stambler et al.
INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2015)
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
Christian T. Ruff et al.
LANCET (2014)
Does cardiac insufficiency receive AVK?
Helene Vaillant-Roussel et al.
EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE (2012)
Warfarin and Aspirin in Patients with Heart Failure and Sinus Rhythm
Shunichi Homma et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation
Robert G. Hart et al.
ANNALS OF INTERNAL MEDICINE (2007)
Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial
S. Connolly et al.
LANCET (2006)
Rationale and design of ACTIVE: The atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events
S. Connolly et al.
AMERICAN HEART JOURNAL (2006)
分享论文
